Ajanta Pharma submits intimation of record date

25 Jan 2024 Evaluate
With reference to letter dated 19th January 2024, informing about the Board meeting scheduled on Wednesday, 31st January 2024 to consider and take on record the unaudited financial results for the third quarter ended 31st December 2023 and pursuant to Regulation 29(1)(e) and 42 of the Listing Regulations, Ajanta Pharma has informed that, at the aforesaid Board Meeting, the Board of Directors will also consider declaration of 2nd interim dividend for the financial year ending 31st March 2024; fixation of Thursday, 8th December 2024 as the Record Date for the payment of 2nd interim dividend, if declared.

The above information is a part of company’s filings submitted to BSE.

Ajanta Pharma Share Price

2960.30 9.75 (0.33%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.